Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.65 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | ACHE | P22303 | 17/20 | 0.53 |
| ▸ | BCHE | P06276 | 16/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | TTPA | P49638 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2058902 | 0.88 | PTGS1 (0.67) | PTGS1PTGS2CYP1A2CYP3A4TSHR | |
| SCHEMBL2059215 | 0.88 | PTGS1 (0.67) | PTGS1PTGS2CYP1A2CYP3A4TSHR | |
| SCHEMBL2059248 | 0.88 | PTGS1 (0.67) | PTGS1PTGS2CYP1A2CYP3A4TSHR | |
| SCHEMBL2058898 | 0.88 | PTGS1 (0.67) | PTGS1PTGS2CYP1A2CYP3A4TSHR | |
| SCHEMBL2059211 | 0.88 | PTGS1 (0.62) | PTGS1PTGS2CYP1A2CYP3A4TSHR | |
| SCHEMBL17289293 | 0.87 | PTGS1 (0.65) | PTGS1PTGS2CYP1A2CYP3A4TSHR | |
| SCHEMBL15820257 | 0.87 | PTGS1 (0.65) | PTGS1PTGS2CYP1A2CYP3A4TSHR | |
| SCHEMBL15426762 | 0.87 | PTGS1 (0.65) | PTGS1PTGS2CYP1A2CYP3A4TSHR | |
| SCHEMBL2059291 | 0.87 | PTGS1 (0.68) | PTGS1PTGS2CYP1A2CYP3A4TSHR | |
| SCHEMBL2058872 | 0.86 | PTGS1 (0.64) | PTGS1PTGS2CYP1A2CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4326892-A1 | METHOD FOR SELECTING ECOBIOLOGICAL TOPICAL COMPOSITIONS AND INGREDIENTS CAPABLE OF RESTORING OR REINFORCING THE SKIN MICROBIOTA | NAOS Institute of Life Science (FR) | 2024-02-28 | — | — | EP | claimed |
| WO-2022223928-A1 | METHOD FOR SELECTING ECOBIOLOGICAL TOPICAL COMPOSITIONS AND INGREDIENTS CAPABLE OF RESTORING OR REINFORCING THE SKIN MICROBIOTA | NAOS INSTITUTE OF LIFE SCIENCE (FR) | 2022-10-27 | — | — | WO | claimed |
| WO-2026104886-A1 | METHOD FOR EXTRACTING LOW-MOLECULAR WEIGHT COLLAGEN USING POLLACK SKIN, LOW-MOLECULAR WEIGHT COLLAGEN, AND COSMETIC COMPOSITION COMPRISING SAME WITH SKIN REGENERATION EFFICACY | 유엔케이코리아 주식회사 | 2026-05-21 | — | — | WO | disclosed |
| US-12350352-B2 | Composition for surface modification | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2025-07-08 | — | — | US | disclosed |
| EP-3342395-B1 | COMPOSITION FOR HAIR SURFACE MODIFICATION | LG HOUSEHOLD & HEALTH CARE LTD (KR) | 2024-08-07 | — | — | EP | disclosed |
| EP-4406617-A2 | COMPOSITION FOR SURFACE MODIFICATION | LG Household & Health Care Ltd. (KR) | 2024-07-31 | — | — | EP | disclosed |
| EP-4326892-A1 | METHOD FOR SELECTING ECOBIOLOGICAL TOPICAL COMPOSITIONS AND INGREDIENTS CAPABLE OF RESTORING OR REINFORCING THE SKIN MICROBIOTA | NAOS Institute of Life Science (FR) | 2024-02-28 | — | — | EP | disclosed |
| US-11904037-B2 | Enzymatic molecule mimicking anti-oxidant activity | BIONUCLEI (FR) | 2024-02-20 | — | — | US | disclosed |
| US-11801208-B2 | Method for topical protection against atmospheric pollutant molecules and/or free radicals produced by exposure to ultraviolet radiation | BIONUCLEI (FR) | 2023-10-31 | — | — | US | disclosed |
| US-11612552-B2 | Composition for surface modification | LG HOUSEHOLD & HEALTH CARE LTD. | 2023-03-28 | — | — | US | disclosed |
| US-20230088314-A1 | Composition For Surface Modification | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2023-03-23 | — | — | US | disclosed |
| WO-2022223928-A1 | METHOD FOR SELECTING ECOBIOLOGICAL TOPICAL COMPOSITIONS AND INGREDIENTS CAPABLE OF RESTORING OR REINFORCING THE SKIN MICROBIOTA | NAOS INSTITUTE OF LIFE SCIENCE (FR) | 2022-10-27 | — | — | WO | disclosed |
| WO-2022114681-A1 | CLEANSER COMPOSITION WITH ENHANCED ACTIVE SUBSTANCE DELIVERY | 주식회사 엘지생활건강 | 2022-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12350352-B2 | Composition for surface modification | CUTA, PTMS, DNMT1 | PTGS1 2945/4885PTGS2 3137/4885CYP1A2 676/4885 |
| US-20230088314-A1 | Composition For Surface Modification | CUTA, PTMS, DNMT1 | PTGS1 2945/4885PTGS2 3137/4885CYP1A2 676/4885 |
| US-11612552-B2 | Composition for surface modification | CUTA, PTMS, DNMT1 | PTGS1 2945/4885PTGS2 3137/4885CYP1A2 676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.